Cart
sales@molnova.com
hCYP3A4 Fluorogenic substrate 1
hCYP3A4 Fluorogenic substrate 1
Catalog No. M37062
hCYP3A4 Fluorogenic substrate 1, a phthalimide derivative, exhibits low activity against COX.
| Size | Price / USD | Stock | Quantity |
| 2MG | 70 | In Stock |
|
| 5MG | 117 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 376 | In Stock |
|
| 50MG | 585 | In Stock |
|
| 100MG | 918 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1841 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamehCYP3A4 Fluorogenic substrate 1
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. He RJ, et al. Rationally Engineered CYP3A4 Fluorogenic Substrates for Functional Imaging Analysis and Drug-Drug Interaction Studies. J Med Chem. 2023 May 25;66(10):6743-6755.?
molnova catalog
related products
-
Meclofenamate Sodium
A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
-
Chemocoxib A
Chemocoxib A is a highly potent, selective, cytotoxic COX-2 inhibitor with IC50 of 290 nM and 90 nM for wt mCOX-2 and R120Q COX-2 mutant respectively.
-
Roflumilast N-oxide
Roflumilast N-oxide is a PDE type 4 inhibitor.
